Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Anti-CD38-CAR IPS-Derived Cytotoxic T Lymphocytes Efficiently Eliminate Myeloma Cells Treated with Daratumumab and Isatuximab in Vitro and In Vivo

Yuji Hattori, Takanori Kubo, Seiji Nagano, Takahiko Miyama, Yoshitaka Taniguchi, Yoshitaka Iba, Nobuko Ohshima, Rie Kanehara, Takakazu Kawase, Masahide Takahashi, Hiroshi Kawamoto, Keichiro Mihara

Blood (2023) 142 (Supplement 1): 3312.

https://doi.org/10.1182/blood-2023-173356

Published: 2023

Journal Articles

Carbapenem Antibiotics Promote Mucus Degradation By Bacteroides and Aggravate Graft-Versus-Host Disease

Eiko Hayase, Tomo Hayase, Chia-Chi Chang, Takahiko Miyama, Jennifer L. Karmouch, Wen-Bin Tsai, Mohamed A. Jamal, Robert R. Jenq

Blood (2021) 138 (Supplement 1): 85.

https://doi.org/10.1182/blood-2021-149848

Published: 2021

Journal Articles

Landscape of Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation Is Superdominated By Distinct T Cell Populations Bearing T-Cell Receptor Clonotypes Shared Among Different Individuals

Takahiko Miyama, MD, Takakazu Kawase, MD PhD, Yasuko Honjo, PhD, Kazutaka Kitaura, DVM, PhD, Tadasu Shin-I, PhD, Ryuji Suzuki, DVM, PhD, Tatsuo Ichinohe, MD PhD

Blood (2017) 130 (Supplement 1): 4502.

https://doi.org/10.1182/blood.V130.Suppl_1.4502.4502

Published: 2017

Journal Articles

Comprehensive T-Cell Receptor Repertoire Analysis Using Deep Sequencing and Single Cell Cloning Reveals Extreme Oligoclonality of Ex Vivo Expanded Cytomegalovirus-Reactive Cytotoxic T-Cells

Takahiko Miyama, MD, Takakazu Kawase, MD PhD, Kazutaka Kitaura, DVM, PhD, Ren Chishaki, Masashi Shibata, Kumi Oshima, MD PhD, Hiroshi Hamana, PhD, Hiroyuki Kishi, PhD, Kiyotaka Kuzushima, MD PhD, Hiroh Saji, BS, Ryuji Suzuki, DVM, PhD, Tatsuo Ichinohe, MD

Blood (2015) 126 (23): 1891.

https://doi.org/10.1182/blood.V126.23.1891.1891

Published: 2015

Journal Articles

BMI1 Collaborates with RUNX1/AML1 Mutants in the Development of Human Myelodysplastic Syndrome (MDS) / Acute Myeloid Leukemia (AML)

Hironori Harada, MD, Ye Ding, MD, Jun Imagawa, MD, Takahiko Miyama, MD, Akiro Kimura, MD, Yuka Harada, MD

Blood (2011) 118 (21): 275.

https://doi.org/10.1182/blood.V118.21.275.275

Published: 2011

NARROW

Anti-CD38-CAR IPS-Derived Cytotoxic T Lymphocytes Efficiently Eliminate Myeloma Cells Treated with Daratumumab and Isatuximab in Vitro and In Vivo

Carbapenem Antibiotics Promote Mucus Degradation By Bacteroides and Aggravate Graft-Versus-Host Disease

Landscape of Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation Is Superdominated By Distinct T Cell Populations Bearing T-Cell Receptor Clonotypes Shared Among Different Individuals

Comprehensive T-Cell Receptor Repertoire Analysis Using Deep Sequencing and Single Cell Cloning Reveals Extreme Oligoclonality of Ex Vivo Expanded Cytomegalovirus-Reactive Cytotoxic T-Cells

BMI1 Collaborates with RUNX1/AML1 Mutants in the Development of Human Myelodysplastic Syndrome (MDS) / Acute Myeloid Leukemia (AML)

Email alerts

ASH Publications

American Society of Hematology

Anti-CD38-CAR IPS-Derived Cytotoxic T Lymphocytes Efficiently Eliminate Myeloma Cells Treated with Daratumumab and Isatuximab in Vitro and In Vivo

Carbapenem Antibiotics Promote Mucus Degradation By Bacteroides and Aggravate Graft-Versus-Host Disease

Landscape of Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation Is Superdominated By Distinct T Cell Populations Bearing T-Cell Receptor Clonotypes Shared Among Different Individuals

Comprehensive T-Cell Receptor Repertoire Analysis Using Deep Sequencing and Single Cell Cloning Reveals Extreme Oligoclonality of Ex Vivo Expanded Cytomegalovirus-Reactive Cytotoxic T-Cells

BMI1 Collaborates with RUNX1/AML1 Mutants in the Development of Human Myelodysplastic Syndrome (MDS) / Acute Myeloid Leukemia (AML)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only